Temporomandibular Joint and COVID-19
Launched by RECEP TAYYIP ERDOGAN UNIVERSITY TRAINING AND RESEARCH HOSPITAL · Oct 13, 2021
Trial Information
Current as of July 25, 2025
Completed
Keywords
ClinConnect Summary
This study investigates the effect of systemic status, according to American Society of Anesthesiologist (ASA), and COVID-19 on temporomandibular joint (TMJ) disorders using the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) scale, shown to be valid for assessing TMJ disorders. The study included 76 patients who presented to our clinic with TMJ. Participants were divided into two groups: those with COVID-19 (CV-19, study group) and those without (non-CV-19, control group). These two groups were both further divided into subgroups according to ASA 1 and ASA 2 classification. Po...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • applied to our clinic with TMJ discomfort
- • ASA 1 and ASA 2 patients
- Exclusion Criteria:
- • patients with acute CV-19
- • Patients who are not in ASA 1 or ASA 2 classification
- • Patients under 18 year-old
- • Pregnants
About Recep Tayyip Erdogan University Training And Research Hospital
Recep Tayyip Erdogan University Training and Research Hospital is a leading healthcare institution dedicated to advancing medical research and patient care. As a clinical trial sponsor, the hospital is committed to fostering innovative research initiatives that enhance treatment outcomes and contribute to the scientific community. With a focus on multidisciplinary collaboration and ethical standards, the hospital provides a robust infrastructure for conducting clinical trials, ensuring rigorous adherence to regulatory guidelines while prioritizing patient safety and welfare. Through its endeavors, Recep Tayyip Erdogan University Training and Research Hospital aims to improve healthcare delivery and contribute to the advancement of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ri̇ze, Eyalet/Yerleşke, Turkey
Ri̇ze, , Turkey
Patients applied
Trial Officials
Nazife B Karan
Principal Investigator
Recep Tayyip Erdogan University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials